Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.
GoodRx Holdings, Inc. operates a digital healthcare platform focused on prescription and medication savings in the United States. Company news commonly covers prescription transaction revenue, retail pharmacy trends, negotiated discount pricing, PBM relationships, and the expansion of Pharma Direct manufacturer programs that connect branded drug discounts to consumers at the pharmacy counter.
GoodRx updates also include self-pay pricing arrangements for GLP-1 and other branded medications, subscription health services such as condition-specific programs, earnings releases, business outlook commentary, and partnerships with pharmaceutical manufacturers, pharmacies, payers, and healthcare professionals.
GoodRx (GDRX) has launched GoodRx Health, a platform providing research-based answers to health questions. This initiative aims to deliver concise, actionable knowledge through various tools including GoodRx Answers and award-winning videos. The platform is backed by an editorial team of doctors and pharmacists, focusing on areas like health knowledge, financial guidance, and trustworthy research. With nearly 20 million monthly users, GoodRx seeks to enhance consumer advocacy in healthcare decisions and capture a larger share of the $30 billion addressable market.
GoodRx Holdings (GDRX) will host a virtual educational webinar, GoodRx 101, for analysts and investors on September 30, 2021, at 11:30 a.m. PT (2:30 p.m. ET). The session will provide an overview of the company's business, though no new financial information will be disclosed. Participants can join via the webcast at investors.goodrx.com or use the dial-in number (833) 614-1447. An archived version of the presentation will be accessible for 30 days post-event.
GoodRx is a leading digital healthcare resource, having helped consumers save over $30 billion since its inception in 2011.
Summary not available.
Summary not available.
GoodRx Holdings (GDRX) announced its participation in three upcoming virtual investor conferences. The events include the Morgan Stanley 19th Annual Global Healthcare Conference on September 10 at 11:00 a.m. PT, the Citi 2021 Global Technology Virtual Conference on September 14 at 9:10 a.m. PT, and the Goldman Sachs 30th Annual Communacopia Conference on September 22 at 11:55 a.m. PT. Live webcasts and archived recordings will be accessible on their Investor Relations website. GoodRx, a leader in healthcare savings, has helped Americans save over $30 billion since 2011.
GoodRx Holdings (GDRX) announced its second quarter 2021 financial results on August 12, with a conference call scheduled to discuss the outcomes and future outlook. The company claims to have saved Americans over $30 billion since 2011, providing affordable healthcare services like telehealth and lab tests. GoodRx emphasizes its role as America’s leading resource for healthcare savings.
Summary not available.
GoodRx, Inc. (Nasdaq: GDRX) and Boehringer Ingelheim have initiated a partnership to enhance access to copay programs for diabetes and COPD medications on the GoodRx platform. This collaboration aims to provide approximately $15 million in annual savings for patients in need of life-enhancing drugs. Diabetes impacts over 10% of the U.S. population, with medical costs considerably higher for affected individuals. With more patients facing increased financial burdens due to insurance changes, this initiative seeks to alleviate some of the cost barriers.
GoodRx (NASDAQ: GDRX) has formed a partnership with Surescripts to integrate drug discount pricing into Surescripts' Real-Time Prescription Benefit system. This collaboration aims to enhance prescription price transparency, particularly for uninsured patients and those lacking price information from their health plans. The initiative could lead to significant savings—up to 80%—on prescriptions, fostering better patient decision-making at the point of care. This effort aligns with GoodRx's mission to improve healthcare affordability for Americans.
GoodRx (NASDAQ: GDRX) recently published a consumer survey revealing its positive impact on pharmacy retailers. Key findings show that GoodRx enhances medication affordability, with 81% of users able to afford all prescriptions after using the service, compared to only 23% beforehand. Additionally, nearly 80% of users reported buying other items while picking up prescriptions, averaging $40 in extra purchases. The survey also indicated that 85% of participants were more likely to return to their pharmacy due to their positive experience with GoodRx, highlighting its role in boosting foot traffic and customer loyalty.